WCLC 2025 - Posters & ePosters-P3.12.62 First-Line Osimertinib ± Platinum-Pemetrexed Chemotherapy for EGFR-Mutated Advanced NSCLC: FLAURA2 Non-Asian Country Cohort

P3.12.62 First-Line Osimertinib ± Platinum-Pemetrexed Chemotherapy for EGFR-Mutated Advanced NSCLC: FLAURA2 Non-Asian Country Cohort

Asset Subtitle

Pasi Janne

Meta Tag

Speaker Pasi Janne

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy